Compare FRPH & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FRPH | QTRX |
|---|---|---|
| Founded | 1986 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.3M | 306.0M |
| IPO Year | 1995 | 2017 |
| Metric | FRPH | QTRX |
|---|---|---|
| Price | $22.75 | $5.01 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.33 |
| AVG Volume (30 Days) | 38.6K | ★ 583.3K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $41,774,000.00 | $37,632,000.00 |
| Revenue This Year | N/A | $25.45 |
| Revenue Next Year | N/A | $13.83 |
| P/E Ratio | $142.44 | ★ N/A |
| Revenue Growth | 0.65 | ★ 64.52 |
| 52 Week Low | $21.68 | $4.15 |
| 52 Week High | $29.68 | $8.77 |
| Indicator | FRPH | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 33.26 |
| Support Level | $21.93 | $4.30 |
| Resistance Level | $24.59 | $5.56 |
| Average True Range (ATR) | 0.50 | 0.43 |
| MACD | -0.17 | -0.09 |
| Stochastic Oscillator | 8.67 | 6.89 |
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.